In countries such as the UK, US and Australia, strict laws and international conventions prohibiting the use of psychedelic drugs have made it almost impossible to research how these drugs work, and how they might be used to heal instead of harm—until recently. These barriers—together with cost, ethics committees, ideologically driven myths and stigma—have delayed research into a promising area of medicine. But things are changing for the better, as evidence and unmet need are at last being recognised.
* This article was originally published here